Apotex Health Corp. logo

Apotex Health Corp. (APTX)

Market Closed
10 Aug, 20:00
TSX TSX
CA$
37. 18
-0.2
-0.535%
CA$
8.71B Market Cap
23.06 P/E Ratio
- Div Yield
224,708 Volume
0 Eps
CA$ 37.38
Previous Close
Add Transaction
Day Range
37.18 38.1
Year Range
26.05 40.18
Want to track APTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

APTX closed today lower at CA$37.18, a decrease of -0.535% from yesterday's close, completing a monthly increase of 15.1084% or CA$4.88. Over the past 12 months, APTX stock gained 32.7857%.
APTX is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on TSX (CAD).

APTX Chart

Apotex Health Corp. (APTX) FAQ

What is the stock price today?

The current price is CA$37.18.

On which exchange is it traded?

Apotex Health Corp. is listed on TSX.

What is its stock symbol?

The ticker symbol is APTX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 8.71B.

Has Apotex Health Corp. ever had a stock split?

No, there has never been a stock split.

Apotex Health Corp. Profile

- Industry
- Sector
Mr. Jeff Watson CEO
TSX Exchange
- ISIN
CA Country
6,216 Employees
30 Sep 2026 Last Dividend
- Last Split
- IPO Date

Overview

Apotex Health Corp. is a prominent pharmaceutical manufacturing company with a significant presence across Canada, the United States, Mexico, and India. Established in 1974, the company has built a reputation for developing, manufacturing, and distributing a diverse range of pharmaceutical products. Its comprehensive portfolio includes prescription medications, generic pharmaceuticals, oncology biosimilars, branded specialty drugs, and consumer health and wellness products. The company operates through three distinct business lines: conventional generic pharmaceuticals, specialty generic pharmaceuticals, and a selection of brands and biosimilars. In May 2026, Apotex Health Corp. changed its name from Artemis Parent, Inc. and continues to expand its global reach while maintaining its headquarters in Toronto, Canada. Furthermore, Apotex Health Corp. benefits from a strategic partnership with Halo Pharmaceutical, Inc., enhancing its innovation and production capabilities. Notably, Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC.

Products and Services

  • Conventional Generic Pharmaceuticals:

    Apotex Health Corp. offers a wide range of traditional generic medications that provide cost-effective alternatives to brand-name drugs. These pharmaceuticals are rigorously tested for quality and effectiveness, ensuring that patients receive safe and reliable options.

  • Specialty Generic Pharmaceuticals:

    This category includes unique generic medications that may not be widely available. Specialty generic pharmaceuticals often target specific health conditions, ensuring that patients with complex health issues have access to essential treatments at competitive prices.

  • Brands & Biosimilars:

    Apotex Health Corp. develops branded specialty pharmaceuticals that are designed to offer innovative treatments. Additionally, the company produces oncology biosimilars, which are biologic medical products highly similar to already approved reference products, providing effective cancer treatment options while promoting affordability.

  • Consumer Health and Wellness Products:

    The company also engages in the production of branded consumer health and wellness items. These products are tailored to enhance overall health and well-being, encompassing various health supplements and over-the-counter offerings that cater to consumer needs.

Contact Information

Address: 150 Signet Drive, Toronto, ON, Canada, M9L 1T9
Phone: (800) 268-4623